University of South Florida H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida

University of South Florida H. Lee Moffitt Cancer Center and Research Institute is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

University of South Florida H. Lee Moffitt Cancer Center and Research Institute has participated in 3 clinical trials.

Therapeutic areas: Cervical Carcinoma, Metastatic Melanoma, HRAS Gene Mutation.

Sponsors: Iovance Biotherapeutics, Inc., Kura Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of South Florida H. Lee Moffitt Cancer Center and Research Institute?

University of South Florida H. Lee Moffitt Cancer Center and Research Institute has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of South Florida H. Lee Moffitt Cancer Center and Research Institute conducted?

University of South Florida H. Lee Moffitt Cancer Center and Research Institute has 3 clinical trials on record. Their work covers Cervical Carcinoma, Metastatic Melanoma, HRAS Gene Mutation.

Is University of South Florida H. Lee Moffitt Cancer Center and Research Institute accredited by Crixeo Health?

University of South Florida H. Lee Moffitt Cancer Center and Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of South Florida H. Lee Moffitt Cancer Center and Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.